Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function.

[1]  T. Liberek,et al.  Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis. , 1995, Kidney international.

[2]  U. Frei,et al.  Peritoneal dialysis fluid biocompatibility: does it really matter? , 1994, Kidney international. Supplement.

[3]  N. Topley,et al.  Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity. , 1994, Kidney international. Supplement.

[4]  S. Argov,et al.  Human peritoneal mesothelial cells synthesize IL-1α and β , 1994 .

[5]  E. Stylianou,et al.  Human peritoneal mesothelial cell prostaglandin synthesis: induction of cyclooxygenase mRNA by peritoneal macrophage-derived cytokines. , 1994, Kidney international.

[6]  N. Topley,et al.  Effect of Three Lipophilic Methotrexate Derivatives Upon Mediator Release by Lipopolysaccharide‐stimulated Rat Peritoneal Macrophages , 1994, The Journal of pharmacy and pharmacology.

[7]  N. Topley,et al.  Effect of liposomally encapsulated MTX-DMPE conjugates upon TNF alpha and PGE2 release by lipopolysaccharide stimulated rat peritoneal macrophages. , 1994, Biochimica et biophysica acta.

[8]  C. Visser,et al.  Analysis of the peritoneal cellular immune system during CAPD shortly before a clinical peritonitis. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  N. Topley,et al.  In-vitro biocompatibility of alternative CAPD fluids; comparison of bicarbonate-buffered and glucose-polymer-based solutions. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  R. Krediet,et al.  Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-alpha, interleukin-1, and medium conditioned by macrophages cocultured with Staphylococcus epidermidis. , 1993, The Journal of infectious diseases.

[11]  T. Liberek,et al.  Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. , 1993, Nephron.

[12]  J. Westwick,et al.  Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1 beta and tumor necrosis factor-alpha. , 1993, The American journal of pathology.

[13]  A. Donker,et al.  Biocompatibility of a glucose-polymer-containing peritoneal dialysis fluid. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  T. Liberek,et al.  Cell Function and Viability in Glucose Polymer Peritoneal Dialysis Fluids , 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[15]  C. Holmes.  Biocompatibility of Peritoneal Dialysis Solutions , 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[16]  A. Donker,et al.  In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD. , 1993, Clinical nephrology.

[17]  T. Liberek,et al.  Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration. , 1993, Journal of the American Society of Nephrology : JASN.

[18]  W. Luttmann,et al.  Human peritoneal mesothelial cells synthesize interleukin-6: Induction by IL-1β and TNFα , 1993 .

[19]  E. Tielens,et al.  Major reduction of CAPD peritonitis after the introduction of the twin-bag system. , 1993, Nephrology, Dialysis and Transplantation.

[20]  T. Ing,et al.  In vitro buffering capacity of residual peritoneal dialysate fluid: implications for peritoneal dialysis therapy. , 2008, Artificial organs.

[21]  T. Ing,et al.  Neutrophilic Intracellular Acidosis Induced by Conventional, Lactate-Containing Peritoneal Dialysis Solutions , 1992, The International journal of artificial organs.

[22]  A. Donker,et al.  Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis. , 1992, Kidney international.

[23]  D. Oreopoulos,et al.  Toxicity of osmotic solutes on human mesothelial cells in vitro. , 1992, Kidney international.

[24]  E. Köttgen,et al.  Inhibition of cytokine synthesis by peritoneal dialysate persists throughout the CAPD cycle. , 1992, American journal of nephrology.

[25]  R. Espinosa,et al.  axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase , 1991, Molecular and cellular biology.

[26]  A. Wieslander,et al.  Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. , 1991, Kidney international.

[27]  J. Rubin,et al.  An autopsy study of the peritoneal cavity from patients on continuous ambulatory peritoneal dialysis. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[28]  A. Raftery,et al.  Mesothelial hyperplasia in response to peritoneal dialysis fluid: a morphometric study in the rat. , 1991, Nephron.

[29]  M. Davies,et al.  In vitro testing of a potentially biocompatible continuous ambulatory peritoneal dialysis fluid. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[30]  E. Köttgen,et al.  Leukotriene B4 and tumor necrosis factor release from leukocytes: effect of peritoneal dialysate. , 1991, Nephron.

[31]  N. Topley,et al.  Leukotriene release from peripheral and peritoneal leukocytes following exposure to peritoneal dialysis solutions. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[32]  E. Stylianou,et al.  Isolation, culture and characterization of human peritoneal mesothelial cells. , 1990, Kidney international.

[33]  N. Benjamin,et al.  Paradoxical effect of bicarbonate on cytoplasmic pH , 1990, The Lancet.

[34]  J. Knowlden,et al.  The assessment of relative surface hydrophobicity as a factor involved in the activation of human polymorphonuclear leukocytes by uropathogenic strains of Escherichia coli. , 1989, Biochimica et biophysica acta.

[35]  Diaz-Buxo Ja.  Comparison of peritonitis rates with CCPD, manual CAPD, Y-sets, O-sets, UV devices and sterile weld. , 1989 .

[36]  A. Sheil,et al.  Peritoneal morphology on maintenance dialysis. , 1989, American journal of nephrology.

[37]  D. Lloyd,et al.  The effect of dialysate on peritoneal phagocyte oxidative metabolism. , 1988, Kidney international.

[38]  D. Dunn,et al.  Macrophages and translymphatic absorption represent the first line of host defense of the peritoneal cavity. , 1987, Archives of surgery.

[39]  J H Korn,et al.  Structure and expression of cDNA and genes for human interferon‐beta‐2, a distinct species inducible by growth‐stimulatory cytokines. , 1986, The EMBO journal.

[40]  J. Watts,et al.  Factors affecting Staphylococcus epidermidis growth in peritoneal dialysis solutions , 1986, Journal of clinical microbiology.

[41]  C. Bartell,et al.  In vitro study of bacterial growth in continuous ambulatory peritoneal dialysis fluids , 1986, Journal of clinical microbiology.

[42]  N. Di Paolo,et al.  Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. , 1986, Nephron.

[43]  M. Redinbaugh,et al.  Adaptation of the dye-binding protein assay to microtiter plates. , 1985, Analytical biochemistry.

[44]  K. Nolph,et al.  Acute changes in peritoneal morphology and transport properties with infectious peritonitis and mechanical injury. , 1983, Kidney international.

[45]  E. Fuchs,et al.  The evolution and complexity of the genes encoding the cytoskeletal proteins of human epidermal cells. , 1983, Current problems in dermatology.

[46]  J. Dobbie,et al.  Ultrastructural Studies on the Peritoneum with Special Reference to Chronic Ambulatory Peritoneal Dialysis , 1981, Scottish medical journal.

[47]  A. Duwe,et al.  Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro , 1981, Infection and immunity.